Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ithaar Derweesh

Showing results (51-60 of 86) with videos related to

Pageof 9
Sort By:
Urologic Oncology|January 21, 2020
Upstaging to pT3a disease in patients undergoing robotic partial nephrectomy for cT1 kidney cancer: Outcomes and predictors from a multi-institutional datasetAlessandro Veccia, Alessandro Antonelli, Andrea Minervini, et al.
European Urology Open Science|August 7, 2023
Selective Use of Neoadjuvant Targeted Therapy Is Associated with Greater Achievement of Partial Nephrectomy for High-complexity Renal Masses in a Solitary KidneyWorapat Attawettayanon, Yosuke Yasuda, Jj H Zhang, et al.
BJU International|January 13, 2026
Impact of ischaemia duration and clamping strategy in patients with solitary kidney undergoing partial nephrectomyFrancesco Cei, Daniele Cignoli, Irene Franco, et al.
European Urology|February 19, 2013
Laparoendoscopic single-site partial nephrectomy: a multi-institutional outcome analysisFrancesco Greco, Riccardo Autorino, Koon H Rha, et al.
European Urology Oncology|January 1, 2021
Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC)Michele Marchioni, Maximilian Kriegmair, Mathias Heck, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 2, 2020
Outcomes of robot-assisted partial nephrectomy for completely endophytic renal tumors: A multicenter analysisUmberto Carbonara, Giuseppe Simone, Andrea Minervini, et al.
European Urology Focus|November 6, 2020
Robotic-assisted Partial Nephrectomy for "Very Small" (<2 cm) Renal Mass: Results of a Multicenter Contemporary CohortUmberto Carbonara, Giuseppe Simone, Andrea Minervini, et al.
European Urology Oncology|May 5, 2021
Corrigendum to 'Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC)' [European Urology Oncology 3 (2021) 256-263]Michele Marchioni, Maximilian Kriegmair, Mathias Heck, et al.
European Urology Open Science|March 6, 2023
The IRON Study: Investigation of Robot-assisted Versus Open Nephron-sparing SurgeryCarlo Andrea Bravi, Giuseppe Rosiello, Elio Mazzone, et al.
Urologic Oncology|August 7, 2022
Practice trends for perioperative intravesical chemotherapy in upper tract urothelial carcinoma: Low but increasing utilization during minimally invasive nephroureterectomyAlexander P Kenigsberg, Gianpaolo Carpinito, Samuel A Gold, et al.
Pageof 9

Showing results (51-60 of 86) with videos related to

Sort By:
Pageof 9
Urologic Oncology|January 21, 2020
Upstaging to pT3a disease in patients undergoing robotic partial nephrectomy for cT1 kidney cancer: Outcomes and predictors from a multi-institutional datasetAlessandro Veccia, Alessandro Antonelli, Andrea Minervini, et al.
European Urology Open Science|August 7, 2023
Selective Use of Neoadjuvant Targeted Therapy Is Associated with Greater Achievement of Partial Nephrectomy for High-complexity Renal Masses in a Solitary KidneyWorapat Attawettayanon, Yosuke Yasuda, Jj H Zhang, et al.
BJU International|January 13, 2026
Impact of ischaemia duration and clamping strategy in patients with solitary kidney undergoing partial nephrectomyFrancesco Cei, Daniele Cignoli, Irene Franco, et al.
European Urology|February 19, 2013
Laparoendoscopic single-site partial nephrectomy: a multi-institutional outcome analysisFrancesco Greco, Riccardo Autorino, Koon H Rha, et al.
European Urology Oncology|January 1, 2021
Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC)Michele Marchioni, Maximilian Kriegmair, Mathias Heck, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 2, 2020
Outcomes of robot-assisted partial nephrectomy for completely endophytic renal tumors: A multicenter analysisUmberto Carbonara, Giuseppe Simone, Andrea Minervini, et al.
European Urology Focus|November 6, 2020
Robotic-assisted Partial Nephrectomy for "Very Small" (<2 cm) Renal Mass: Results of a Multicenter Contemporary CohortUmberto Carbonara, Giuseppe Simone, Andrea Minervini, et al.
European Urology Oncology|May 5, 2021
Corrigendum to 'Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC)' [European Urology Oncology 3 (2021) 256-263]Michele Marchioni, Maximilian Kriegmair, Mathias Heck, et al.
European Urology Open Science|March 6, 2023
The IRON Study: Investigation of Robot-assisted Versus Open Nephron-sparing SurgeryCarlo Andrea Bravi, Giuseppe Rosiello, Elio Mazzone, et al.
Urologic Oncology|August 7, 2022
Practice trends for perioperative intravesical chemotherapy in upper tract urothelial carcinoma: Low but increasing utilization during minimally invasive nephroureterectomyAlexander P Kenigsberg, Gianpaolo Carpinito, Samuel A Gold, et al.
Pageof 9